Solid Biosciences Inc (SLDB)
10.43
+0.46
(+4.61%)
USD |
NASDAQ |
May 07, 16:00
10.43
0.00 (0.00%)
After-Hours: 20:00
Solid Biosciences Net Income (TTM): -96.02M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -96.02M |
| September 30, 2023 | -90.83M |
| June 30, 2023 | -90.26M |
| March 31, 2023 | -90.72M |
| December 31, 2022 | -85.98M |
| September 30, 2022 | -89.44M |
| June 30, 2022 | -87.01M |
| March 31, 2022 | -80.62M |
| December 31, 2021 | -72.19M |
| September 30, 2021 | -74.94M |
| June 30, 2021 | -78.20M |
| March 31, 2021 | -78.50M |
| December 31, 2020 | -88.29M |
| Date | Value |
|---|---|
| September 30, 2020 | -98.79M |
| June 30, 2020 | -106.80M |
| March 31, 2020 | -114.34M |
| December 31, 2019 | -117.22M |
| September 30, 2019 | -107.28M |
| June 30, 2019 | -97.05M |
| March 31, 2019 | -88.50M |
| December 31, 2018 | -74.80M |
| September 30, 2018 | -67.36M |
| June 30, 2018 | -61.85M |
| March 31, 2018 | -55.18M |
| December 31, 2017 | -52.12M |
| September 30, 2017 | -45.39M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-117.22M
Minimum
Dec 2019
-72.19M
Maximum
Dec 2021
-91.81M
Average
-90.26M
Median
Jun 2023
Net Income (TTM) Benchmarks
| Sarepta Therapeutics Inc | 16.90M |
| PTC Therapeutics Inc | -579.22M |
| Capricor Therapeutics Inc | -22.29M |
| Perspective Therapeutics Inc | -46.51M |
| Electromed Inc | 3.937M |